ClinicalTrials.gg
CompletedNCT05429203Updated Sep 15, 2025Results posted

Comparison of Duodenoscope With Single-use Distal Cover and the Conventional Reusable Duodenoscope

An interventional study of Duodenoscope with single-use distal cover and Conventional duodenoscope in Biliary Disease, Pancreatic Disease and Choledocholithiasis, sponsored by Stanford University. Completed at 1 site in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2025-09-15.

Sponsored by Stanford University · Not applicable, Interventional, and Other

Phase
Not applicable
Study type
Interventional
Enrollment
319
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

The purpose of the study is to compare the success rates of procedure success and complication rates in patients undergoing Endoscopic retrograde cholangiopancreatography (ERCP) using two types of currently available endoscopes. These are (1) duodenoscope with a Single-use distal cover or (2) a conventional reusable duodenoscope.

Read the detailed description

The risks associated with the ERCP procedure will be explained to patients who meets the eligibility criteria. Consenting patients will be randomized to undergo Endoscopic retrograde cholangiopancreatography (ERCP) using either (1) a duodenoscope with a Single-use distal cover or (2) a conventional reusable duodenoscope. Assessments will be made during, and immediately after the procedure, then patients will be called after 1 week, 1 month, and 3 months after the procedure to get information about adverse events.

02

Conditions studied

  • Biliary Disease
  • Pancreatic Disease
  • Choledocholithiasis
  • Biliary Obstruction
  • Biliary Tract Neoplasms
  • Pancreatic Neoplasms

Keywords

  • ERCP
  • Duodenoscope
  • Duodenoscope with single-use distal cover
03

In context

Gallbladder Diseases

92 studies on the registry are indexed under Gallbladder Diseases; 19 are open to participants now.

This study's enrollment of 319 is above the median of 72 across 59 interventional studies indexed under Gallbladder Diseases.

Browse Gallbladder Diseases studies →

Lead sponsor

Stanford University is the lead sponsor of 2,168 studies on the registry; 431 are open to participants now.

Of its 267 completed or terminated interventional studies of FDA-regulated products, 207 (78%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Patients undergoing ERCP for biliary and pancreatic conditions
  • Age > 18 years old

Exclusion criteria

Exclusion Criteria:

  • Vulnerable patient groups including pregnant women
  • Patients who are unable to consent
  • Patients with known cholangitis
  • Patients with known Carbapenem-Resistant Enterobacteriaceae (CRE) or any other multi-drug resistant organisms (MDRO) infection
  • Surgically altered anatomy except for Billroth I
05

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Participant, Outcomes assessor)
Enrollment
319 participants (actual)

Study arms

  • Active comparator
    Duodenoscope with single-use distal cover

    Patients will undergo ERCP using a duodenoscope with a single-use distal cover

    Device: Duodenoscope with single-use distal cover

  • Active comparator
    Conventional Duodenoscope

    Patients will undergo ERCP using a conventional duodenoscope

    Device: Conventional duodenoscope

Interventions

  • DeviceDuodenoscope with single-use distal cover

    Newer duodenoscope with a single-use distal cover

  • DeviceConventional duodenoscope

    Conventional duodenoscope with standard methods of reprocessing

06

What researchers measure

Primary outcomes

  1. Number of Participants With Procedure-related Adverse Events

    Patients undergoing Endoscopic retrograde cholangiopancreatography (ERCP) using either of the 2 duodenoscopes were assessed for superficial mucosal injury, perforation of the stomach or intestine, mucosal bleeding, pancreatitis, infection, death or any other symptom reported by the patient.

    Time frame: 3 months

Secondary outcomes

  1. Duodenoscope Maneuverability: Intubation Into Esophagus

    Providers assessed the 2 duodenoscopes for maneuverability during the procedure in patients undergoing ERCP, using a previously defined scoring system which uses a 5-point scale ranging from 1 to 5, with 1 being easy to perform, 2 minimal difficulty, 3 moderate difficulty, 4 severe difficulty and 5 unable to complete the requisite maneuver.

    Time frame: Maneuverability will be assessed only during the procedure (approximately 10 minutes)

  2. Duodenoscope Maneuverability: Passage Into Stomach

    Providers assessed the 2 duodenoscopes for maneuverability during the procedure in patients undergoing ERCP, using a previously defined scoring system which uses a 5-point scale ranging from 1 to 5, with 1 being easy to perform, 2 minimal difficulty, 3 moderate difficulty, 4 severe difficulty and 5 unable to complete the requisite maneuver.

    Time frame: Maneuverability will be assessed only during the procedure (approximately 10 minutes)

  3. Duodenoscope Maneuverability: Navigation Across Pylorus

    Providers assessed the 2 duodenoscopes for maneuverability during the procedure in patients undergoing ERCP, using a previously defined scoring system which uses a 5-point scale ranging from 1 to 5, with 1 being easy to perform, 2 minimal difficulty, 3 moderate difficulty, 4 severe difficulty and 5 unable to complete the requisite maneuver.

    Time frame: Maneuverability will be assessed only during the procedure (approximately 10 minutes)

  4. Duodenoscope Maneuverability: Achieving Short Position of the Scope

    Providers assessed the 2 duodenoscopes for maneuverability during the procedure in patients undergoing ERCP, using a previously defined scoring system which uses a 5-point scale ranging from 1 to 5, with 1 being easy to perform, 2 minimal difficulty, 3 moderate difficulty, 4 severe difficulty and 5 unable to complete the requisite maneuver.

    Time frame: Maneuverability will be assessed only during the procedure (approximately 10 minutes)

  5. Duodenoscope Maneuverability: Achieving Optimal Papillary Position

    Providers assessed the 2 duodenoscopes for maneuverability during the procedure in patients undergoing ERCP, using a previously defined scoring system which uses a 5-point scale ranging from 1 to 5, with 1 being easy to perform, 2 minimal difficulty, 3 moderate difficulty, 4 severe difficulty and 5 unable to complete the requisite maneuver.

    Time frame: Maneuverability will be assessed only during the procedure (approximately 10 minutes)

  6. Duodenoscope Mechanical Characteristics Profile: Scope Stiffness

    Providers assessed the 2 duodenoscopes for their mechanical characteristics during the procedure in patients undergoing ERCP. Each characteristic was assessed using a published 5-point scoring system, with 1 being easy to perform, 2 minimal difficulty, 3 moderate difficulty, 4 severe difficulty and 5 unable to complete the requisite maneuver.

    Time frame: Mechanical characteristics assessed only during the procedure (approximately 15 minutes)

  7. Duodenoscope Mechanical Characteristics Profile: Air-water Button Functionality

    Providers assessed the 2 duodenoscopes for their mechanical characteristics during the procedure in patients undergoing ERCP. Each characteristic was assessed using a published 5-point scoring system, with 1 being no water leakage or no difficulty in applying suction or inflating air, 2 minimal leakage or minimal difficulty with suction or inflation, 3 moderate leakage or difficulty, 4 severe leakage or difficulty and 5 unable to perform the requisite function.

    Time frame: Mechanical characteristics assessed only during the procedure (approximately 15 minutes)

  8. Duodenoscope Mechanical Characteristics Profile: Elevator Efficiency

    Providers assessed the 2 duodenoscopes for their mechanical characteristics during the procedure in patients undergoing ERCP. Each characteristic was assessed using a published 5-point scoring system, with 1 being easy to perform, 2 minimal difficulty, 3 moderate difficulty, 4 severe difficulty and 5 unable to complete the requisite maneuver.

    Time frame: Mechanical characteristics assessed only during the procedure (approximately 15 minutes)

  9. Duodenoscope Mechanical Characteristics Profile: Hand Strain

    Providers assessed the 2 duodenoscopes for their mechanical characteristics during the procedure in patients undergoing ERCP. Each characteristic was assessed using a published 5-point scoring system, with 1 being no strain, 2 minimal strain, 3 moderate strain, 4 severe strain and 5 unable to complete the procedure.

    Time frame: Mechanical characteristics assessed only during the procedure (approximately 15 minutes)

  10. Duodenoscope Imaging Characteristics Profile: Image Quality

    Providers assessed the 2 duodenoscopes for their imaging characteristics during the procedure in patients undergoing ERCP. Each characteristic was assessed using a published 5-point scoring system, with 1 being superior, 2 good, 3 satisfactory, 4 suboptimal and 5 unable to visualize or achieve stability of image resulting in termination of procedure.

    Time frame: Imaging characteristics were assessed only during the procedure (approximately 15 minutes)

  11. Duodenoscope Imaging Characteristics Profile: Image Stability

    Providers assessed the 2 duodenoscopes for their imaging characteristics during the procedure in patients undergoing ERCP. Each characteristic was assessed using a published 5-point scoring system, with 1 being superior, 2 good, 3 satisfactory, 4 suboptimal and 5 unable to visualize or achieve stability of image resulting in termination of procedure.

    Time frame: Imaging characteristics were assessed only during the procedure (approximately 15 minutes)

  12. Number of Participant With Procure Success (Ability to Perform Interventions)

    Patients undergoing Endoscopic retrograde cholangiopancreatography (ERCP) using either of the 2 duodenoscopes will be assessed for their ability to perform endoscopic maneuvers like sphincterotomy, balloon sweep, use of basket/mechanical lithotriptor, stone clearance, stricture dilation using balloon/catheter, stent insertion, stent removal and use of single operator cholangioscopy/pancreatoscopy.

    Time frame: 30-60 minutes

07

Results

Posted Sep 15, 2025

Participant flow

Participant flow — Overall Study
MilestoneDuodenoscope With Disposable Distal End CapsConventional Reusable Duodenoscope
Started159160
Completed159160
Not completed00

Outcome measures

PrimaryNumber of Participants With Procedure-related Adverse Events

Patients undergoing Endoscopic retrograde cholangiopancreatography (ERCP) using either of the 2 duodenoscopes were assessed for superficial mucosal injury, perforation of the stomach or intestine, mucosal bleeding, pancreatitis, infection, death or any other symptom reported by the patient.

Time frame:
3 months
Reported as:
Count of participants · Participants
Number of Participants With Procedure-related Adverse Events
ParticipantsDuodenoscope With Disposable Distal End CapsConventional Reusable Duodenoscope
Number of Participants With Procedure-related Adverse Events89
Statistical analysis
  • Duodenoscope With Disposable Distal End Caps vs Conventional Reusable Duodenoscope · Chi-squared · p = 0.8 (The a priori threshold for statistical significance was \<0.05.)
SecondaryDuodenoscope Maneuverability: Intubation Into Esophagus

Providers assessed the 2 duodenoscopes for maneuverability during the procedure in patients undergoing ERCP, using a previously defined scoring system which uses a 5-point scale ranging from 1 to 5, with 1 being easy to perform, 2 minimal difficulty, 3 moderate difficulty, 4 severe difficulty and 5 unable to complete the requisite maneuver.

Time frame:
Maneuverability will be assessed only during the procedure (approximately 10 minutes)
Reported as:
Count of participants · Participants
Duodenoscope Maneuverability: Intubation Into Esophagus
ParticipantsDuodenoscope With Disposable Distal End CapsConventional Reusable Duodenoscope
Rating = 1153154
Rating = 255
Rating = 311
Rating = 400
Rating = 500
Statistical analysis
  • Duodenoscope With Disposable Distal End Caps vs Conventional Reusable Duodenoscope · Fisher Exact · p = 1 (The a priori threshold for statistical significance was \<0.05.)
SecondaryDuodenoscope Maneuverability: Passage Into Stomach

Providers assessed the 2 duodenoscopes for maneuverability during the procedure in patients undergoing ERCP, using a previously defined scoring system which uses a 5-point scale ranging from 1 to 5, with 1 being easy to perform, 2 minimal difficulty, 3 moderate difficulty, 4 severe difficulty and 5 unable to complete the requisite maneuver.

Time frame:
Maneuverability will be assessed only during the procedure (approximately 10 minutes)
Reported as:
Count of participants · Participants
Duodenoscope Maneuverability: Passage Into Stomach
ParticipantsDuodenoscope With Disposable Distal End CapsConventional Reusable Duodenoscope
Rating = 1153155
Rating = 232
Rating = 332
Rating = 401
Rating = 500
Statistical analysis
  • Duodenoscope With Disposable Distal End Caps vs Conventional Reusable Duodenoscope · Fisher Exact · p = 0.7 (The a priori threshold for statistical significance was \<0.05.)
SecondaryDuodenoscope Maneuverability: Navigation Across Pylorus

Providers assessed the 2 duodenoscopes for maneuverability during the procedure in patients undergoing ERCP, using a previously defined scoring system which uses a 5-point scale ranging from 1 to 5, with 1 being easy to perform, 2 minimal difficulty, 3 moderate difficulty, 4 severe difficulty and 5 unable to complete the requisite maneuver.

Time frame:
Maneuverability will be assessed only during the procedure (approximately 10 minutes)
Reported as:
Count of participants · Participants
Duodenoscope Maneuverability: Navigation Across Pylorus
ParticipantsDuodenoscope With Disposable Distal End CapsConventional Reusable Duodenoscope
Rating = 1151155
Rating = 234
Rating = 311
Rating = 420
Rating = 520
Statistical analysis
  • Duodenoscope With Disposable Distal End Caps vs Conventional Reusable Duodenoscope · Fisher Exact · p = 0.4 (The a priori threshold for statistical significance was \<0.05.)
SecondaryDuodenoscope Maneuverability: Achieving Short Position of the Scope

Providers assessed the 2 duodenoscopes for maneuverability during the procedure in patients undergoing ERCP, using a previously defined scoring system which uses a 5-point scale ranging from 1 to 5, with 1 being easy to perform, 2 minimal difficulty, 3 moderate difficulty, 4 severe difficulty and 5 unable to complete the requisite maneuver.

Time frame:
Maneuverability will be assessed only during the procedure (approximately 10 minutes)
Reported as:
Count of participants · Participants
Duodenoscope Maneuverability: Achieving Short Position of the Scope
ParticipantsDuodenoscope With Disposable Distal End CapsConventional Reusable Duodenoscope
Rating = 1154155
Rating = 234
Rating = 321
Rating = 400
Rating = 500
Statistical analysis
  • Duodenoscope With Disposable Distal End Caps vs Conventional Reusable Duodenoscope · Fisher Exact · p = 0.8 (The a priori threshold for statistical significance was \<0.05.)
SecondaryDuodenoscope Maneuverability: Achieving Optimal Papillary Position

Providers assessed the 2 duodenoscopes for maneuverability during the procedure in patients undergoing ERCP, using a previously defined scoring system which uses a 5-point scale ranging from 1 to 5, with 1 being easy to perform, 2 minimal difficulty, 3 moderate difficulty, 4 severe difficulty and 5 unable to complete the requisite maneuver.

Time frame:
Maneuverability will be assessed only during the procedure (approximately 10 minutes)
Reported as:
Count of participants · Participants
Duodenoscope Maneuverability: Achieving Optimal Papillary Position
ParticipantsDuodenoscope With Disposable Distal End CapsConventional Reusable Duodenoscope
Rating = 1154154
Rating = 244
Rating = 312
Rating = 400
Rating = 500
Statistical analysis
  • Duodenoscope With Disposable Distal End Caps vs Conventional Reusable Duodenoscope · Fisher Exact · p = 0.8 (The a priori threshold for statistical significance was \<0.05.)
SecondaryDuodenoscope Mechanical Characteristics Profile: Scope Stiffness

Providers assessed the 2 duodenoscopes for their mechanical characteristics during the procedure in patients undergoing ERCP. Each characteristic was assessed using a published 5-point scoring system, with 1 being easy to perform, 2 minimal difficulty, 3 moderate difficulty, 4 severe difficulty and 5 unable to complete the requisite maneuver.

Time frame:
Mechanical characteristics assessed only during the procedure (approximately 15 minutes)
Reported as:
Count of participants · Participants
Duodenoscope Mechanical Characteristics Profile: Scope Stiffness
ParticipantsDuodenoscope With Disposable Distal End CapsConventional Reusable Duodenoscope
Rating = 1155155
Rating = 245
Rating = 300
Rating = 400
Rating = 500
Statistical analysis
  • Duodenoscope With Disposable Distal End Caps vs Conventional Reusable Duodenoscope · Fisher Exact · p = 0.7 (The a priori threshold for statistical significance was \<0.05.)
SecondaryDuodenoscope Mechanical Characteristics Profile: Air-water Button Functionality

Providers assessed the 2 duodenoscopes for their mechanical characteristics during the procedure in patients undergoing ERCP. Each characteristic was assessed using a published 5-point scoring system, with 1 being no water leakage or no difficulty in applying suction or inflating air, 2 minimal leakage or minimal difficulty with suction or inflation, 3 moderate leakage or difficulty, 4 severe leakage or difficulty and 5 unable to perform the requisite function.

Time frame:
Mechanical characteristics assessed only during the procedure (approximately 15 minutes)
Reported as:
Count of participants · Participants
Duodenoscope Mechanical Characteristics Profile: Air-water Button Functionality
ParticipantsDuodenoscope With Disposable Distal End CapsConventional Reusable Duodenoscope
Rating = 1155156
Rating = 234
Rating = 310
Rating = 400
Rating = 500
Statistical analysis
  • Duodenoscope With Disposable Distal End Caps vs Conventional Reusable Duodenoscope · Fisher Exact · p = 0.6 (The a priori threshold for statistical significance was \<0.05.)
SecondaryDuodenoscope Mechanical Characteristics Profile: Elevator Efficiency

Providers assessed the 2 duodenoscopes for their mechanical characteristics during the procedure in patients undergoing ERCP. Each characteristic was assessed using a published 5-point scoring system, with 1 being easy to perform, 2 minimal difficulty, 3 moderate difficulty, 4 severe difficulty and 5 unable to complete the requisite maneuver.

Time frame:
Mechanical characteristics assessed only during the procedure (approximately 15 minutes)
Reported as:
Count of participants · Participants
Duodenoscope Mechanical Characteristics Profile: Elevator Efficiency
ParticipantsDuodenoscope With Disposable Distal End CapsConventional Reusable Duodenoscope
Rating = 1157158
Rating = 212
Rating = 310
Rating = 400
Rating = 500
Statistical analysis
  • Duodenoscope With Disposable Distal End Caps vs Conventional Reusable Duodenoscope · Fisher Exact · p = 0.5 (The a priori threshold for statistical significance was \<0.05.)
SecondaryDuodenoscope Mechanical Characteristics Profile: Hand Strain

Providers assessed the 2 duodenoscopes for their mechanical characteristics during the procedure in patients undergoing ERCP. Each characteristic was assessed using a published 5-point scoring system, with 1 being no strain, 2 minimal strain, 3 moderate strain, 4 severe strain and 5 unable to complete the procedure.

Time frame:
Mechanical characteristics assessed only during the procedure (approximately 15 minutes)
Reported as:
Count of participants · Participants
Duodenoscope Mechanical Characteristics Profile: Hand Strain
ParticipantsDuodenoscope With Disposable Distal End CapsConventional Reusable Duodenoscope
Rating = 1157158
Rating = 222
Rating = 300
Rating = 400
Rating = 500
Statistical analysis
  • Duodenoscope With Disposable Distal End Caps vs Conventional Reusable Duodenoscope · Fisher Exact · p = 0.9 (The a priori threshold for statistical significance was \<0.05.)
SecondaryDuodenoscope Imaging Characteristics Profile: Image Quality

Providers assessed the 2 duodenoscopes for their imaging characteristics during the procedure in patients undergoing ERCP. Each characteristic was assessed using a published 5-point scoring system, with 1 being superior, 2 good, 3 satisfactory, 4 suboptimal and 5 unable to visualize or achieve stability of image resulting in termination of procedure.

Time frame:
Imaging characteristics were assessed only during the procedure (approximately 15 minutes)
Reported as:
Count of participants · Participants
Duodenoscope Imaging Characteristics Profile: Image Quality
ParticipantsDuodenoscope With Disposable Distal End CapsConventional Reusable Duodenoscope
Rating = 1154154
Rating = 244
Rating = 312
Rating = 400
Rating = 500
Statistical analysis
  • Duodenoscope With Disposable Distal End Caps vs Conventional Reusable Duodenoscope · Fisher Exact · p = 0.8 (The a priori threshold for statistical significance was \<0.05.)
SecondaryDuodenoscope Imaging Characteristics Profile: Image Stability

Providers assessed the 2 duodenoscopes for their imaging characteristics during the procedure in patients undergoing ERCP. Each characteristic was assessed using a published 5-point scoring system, with 1 being superior, 2 good, 3 satisfactory, 4 suboptimal and 5 unable to visualize or achieve stability of image resulting in termination of procedure.

Time frame:
Imaging characteristics were assessed only during the procedure (approximately 15 minutes)
Reported as:
Count of participants · Participants
Duodenoscope Imaging Characteristics Profile: Image Stability
ParticipantsDuodenoscope With Disposable Distal End CapsConventional Reusable Duodenoscope
Rating = 1156157
Rating = 233
Rating = 300
Rating = 400
Rating = 500
Statistical analysis
  • Duodenoscope With Disposable Distal End Caps vs Conventional Reusable Duodenoscope · Fisher Exact · p = 0.9 (the a priori threshold for statistical significance was \<0.05.)
SecondaryNumber of Participant With Procure Success (Ability to Perform Interventions)

Patients undergoing Endoscopic retrograde cholangiopancreatography (ERCP) using either of the 2 duodenoscopes will be assessed for their ability to perform endoscopic maneuvers like sphincterotomy, balloon sweep, use of basket/mechanical lithotriptor, stone clearance, stricture dilation using balloon/catheter, stent insertion, stent removal and use of single operator cholangioscopy/pancreatoscopy.

Time frame:
30-60 minutes
Reported as:
Count of participants · Participants
Number of Participant With Procure Success (Ability to Perform Interventions)
ParticipantsDuodenoscope With Disposable Distal End CapsConventional Reusable Duodenoscope
Number of Participant With Procure Success (Ability to Perform Interventions)154155

Adverse events

Collected over 3 months. Non-serious events are listed at a 5% frequency threshold.

Adverse event summary by group
GroupDeathsSeriousOther
Duodenoscope With Disposable Distal End Caps1/159 (0.6%)8/159 (5%)8/159 (5%)
Conventional Reusable Duodenoscope0/160 (0%)9/160 (5.6%)8/160 (5%)
Most frequent serious events
Most frequent serious events
EventDuodenoscope With Disposable Distal End CapsConventional Reusable Duodenoscope
Post ERCP pancreatitis (PEP)Gastrointestinal disorders6/1595/160
Post-sphincterotomy bleedingSurgical and medical procedures1/1593/160
CholangitisHepatobiliary disorders1/1591/160
PerforationSurgical and medical procedures1/1591/160
Liver failureHepatobiliary disorders1/1590/160
Most frequent other events
Most frequent other events
EventDuodenoscope With Disposable Distal End CapsConventional Reusable Duodenoscope
Abdomen pain (without post-ERCP pancreatitis)Gastrointestinal disorders8/1598/160

Baseline characteristics

Age, Continuous
Age, Continuous(years)Duodenoscope With Disposable Distal End CapsConventional Reusable DuodenoscopeTotal
Median64.5 (48 to 72.7)65 (52 to 72.5)65 (50 to 73)
Sex: Female, Male
Sex: Female, Male(Participants)Duodenoscope With Disposable Distal End CapsConventional Reusable DuodenoscopeTotal
Female5674130
Male10386189
Race (NIH/OMB)
Race (NIH/OMB)(Participants)Duodenoscope With Disposable Distal End CapsConventional Reusable DuodenoscopeTotal
American Indian or Alaska Native000
Asian414889
Native Hawaiian or Other Pacific Islander000
Black or African American273360
White7562137
More than one race000
Unknown or Not Reported161733
Region of Enrollment
Region of Enrollment(Participants)Duodenoscope With Disposable Distal End CapsConventional Reusable DuodenoscopeTotal
United States159160319
Previous ERCP
Previous ERCP(Participants)Duodenoscope With Disposable Distal End CapsConventional Reusable DuodenoscopeTotal
Index454489
Repeat114116230
08

Study locations

1 site
  • Stanford hospital
    Palo Alto, California 943305, United States
09

References and documents

Publications

  • Bang JY, Rosch T, Kim HM, Thakkar S, Robalino Gonzaga E, Tharian B, Inamdar S, Lee LS, Yachimski P, Jamidar P, Muniraj T, DiMaio C, Kumta N, Sethi A, Draganov P, Yang D, Seoud T, Perisetti A, Bondi G, Kirtane S, Hawes R, Wilcox CM, Kozarek R, Reddy DN, Varadarajulu S. Prospective evaluation of an assessment tool for technical performance of duodenoscopes. Dig Endosc. 2021 Jul;33(5):822-828. doi: 10.1111/den.13856. Epub 2020 Nov 17. PubMed 33007136 ↗

Study documents

PDFs hosted by the registry, ClinicalTrials.gov.

Individual participant data

Plan to share: No

10

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Sep 15, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
11

Registry details

Key details

Study ID
NCT05429203
Responsible party
Subhas Banerjee (Professor of Medicine, Stanford University) — Principal investigator
First posted
Jun 23, 2022
Start date
Oct 25, 2022
Primary completion
Jul 29, 2024
Completion
Jul 29, 2024
Results posted
Sep 15, 2025
Last update
Sep 15, 2025

Study contacts

Subhas Banerjee, MD
principal investigator · Stanford University

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Aug 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion